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        Bronchus-associated lymphoid tissue (BALT) 
is part of the mucosal immune system of the 
lung and is characterized by the aggregation of 
lymphoid cells at the bifurcations of the upper 
bronchioles (  Bienenstock and Befus, 1984  ). 
Like other lymphoid follicles, BALT is com-
posed of B cells surrounded by a parafollicular 
region of T cells (  Sminia et al., 1989  ). Recir-
culating lymphocytes are believed to enter 
BALT via high endothelial venules and leave 
these structures by eff  erent  lymphatics 
(  Lührmann et al., 2002/2003  ;   Xu et al., 2003  ). 
Although BALT is largely absent in normal 
mice, it spontaneously forms in mice defi  cient 
for the chemokine receptor CCR7 (  Kocks 
et al., 2007  ). In humans, it is neither found at 
birth nor in healthy adults but transiently arises 
during childhood and adolescence (  Tschernig 
and Pabst, 2000  ). In both humans and mice, 
pulmonary infection and infl  ammation can in-
duce BALT (  Moyron-Quiroz et al., 2004  ). 
Data derived from splenectomized lympho-
toxin-    –defi   cient mice, which lack all sec-
ondary lymphoid organs but do develop BALT, 
suggest that BALT can serve as induction sites 
for adaptive immune responses to pathogens 
with lung tropism (  Moyron-Quiroz et al., 
2004  ). However, mechanisms that control the 
development and maintenance of BALT are 
largely unknown. 
  Modifi  ed vaccinia virus Ankara (MVA) is a 
highly attenuated orthopoxvirus that lost its ca-
pacity to replicate in mammalian cells (  Meyer 
et al., 1991  ). Recently, MVA was proposed to 
represent a useful agent for mucosal vaccination 
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  Mucosal vaccination via the respiratory tract can elicit protective immunity in animal 
infection models, but the underlying mechanisms are still poorly understood. We show 
that a single intranasal application of the replication-defi  cient modifi  ed vaccinia virus 
Ankara, which is widely used as a recombinant vaccination vector, results in prominent 
induction of bronchus-associated lymphoid tissue (BALT). Although initial peribronchiolar 
infi  ltrations, characterized by the presence of dendritic cells (DCs) and few lymphocytes, 
can be found 4 d after virus application, organized lymphoid structures with segregated B 
and T cell zones are fi  rst observed at day 8. After intratracheal application, in vitro–
differentiated, antigen-loaded DCs rapidly migrate into preformed BALT and effi  ciently 
activate antigen-specifi  c T cells, as revealed by two-photon microscopy. Furthermore, the 
lung-specifi  c depletion of DCs in mice that express the diphtheria toxin receptor under 
the control of the CD11c promoter interferes with BALT maintenance. Collectively, these 
data identify BALT as tertiary lymphoid structures supporting the effi  cient priming of T 
cell responses directed against unrelated airborne antigens while crucially requiring DCs 
for its sustained presence. 
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  Virus-encoded gene expression and recruitment 
of infl  ammatory cells after i.n. application of MVA 
  To monitor productive MVA infection and viral gene expres-
sion in the lung, we used an MVA strain encoding an en-
hanced GFP (EGFP;   Lehmann et al., 2009  ). Within 5–7 h 
after i.n. infection, high numbers of GFP  bright   cells could be 
detected in the bronchioalveolar lavage (BAL) of MVA-GFP–
infected but not MVA-WT–infected animals (  Fig. 2, A and B  ).   
via the respiratory route in a nonhuman primate model 
(  Corbett et al., 2008  ). In mice, MVA delivered via the intra-
nasal (i.n.) route has been shown to induce long-lasting and 
protective antibody and T cell immune responses (  Gherardi 
and Esteban, 2005  ;   Kastenmuller et al., 2009  ). However, lit-
tle is known about the immunological events after respiratory 
MVA infection. 
  The present report demonstrates that a single i.n. appli-
cation of the replication-defi   cient MVA is suffi   cient  to 
induce the long-lasting presence of BALT and that the 
lung-specifi  c depletion of DCs interferes with BALT main-
tenance. Ex vivo imaging of antigen-specifi  c T cell–DC in-
teractions within BALT by two-photon microscopy indicates 
that, independent of the specifi  c antigenic challenge induc-
ing its formation, BALT can function as a general priming 
site for T cell responses directed against antigens that reach 
the lower respiratory tract. 
  RESULTS AND DISCUSSION 
  A single i.n. application of replication-defi  cient MVA 
suffi  ces to induces highly organized BALT 
  We have recently shown that i.n. infection with the mouse 
    -herpesvirus MHV-68 induces BALT in mice and that 
BALT actually serves as a reservoir of latent MHV-68 
(  Kocks et al., 2009  ). To address the question of whether 
latent or continuous reinfection of host cells with virus is 
required for the induction and/or maintenance of BALT, 
we tested the replication-defi  cient poxvirus MVA for its 
ability to induce BALT. Although the peribronchiolar space 
in lungs of untreated mice contained only few CD11c  +   cells 
and hardly any lymphocytes (  Fig. 1 A   and not depicted), a 
massive perivascular and peribronchiolar infi  ltration  of 
CD11c  +   cells could be observed 4 d after i.n. application of 
10  7   infectious units (IU) MVA (  Fig. 1 B  ).   At day 8 after in-
fection, B and T cells had been recruited to CD11c  +   cell–
rich areas (  Fig. 1, C and D  ). Although in some areas B and 
T cells were still scattered diff  usely around vessels and bron-
chioles (  Fig. 1 C  ) at this time point, we also frequently ob-
served areas in which B cells started to segregate toward the 
center of BALT structures (  Fig. 1 D  ). By day 12, large areas 
of BALT had been formed. Frequently, CD11c  +   cells were 
found surrounding the structures (  Fig. 1 E  ), whereas B and 
T cells exhibited various degrees of clustering (  Fig. 1 F  ). At 
day 28 after infection, the MVA-induced BALT displayed 
a pronounced segregation into T and B cell–rich areas 
(  Fig. 1 G  ). In this diff  erentiated BALT, DCs were found to 
reside primarily in the T cell areas (  Fig. 1 H  ). Quantitative 
analysis revealed that BALT structures were most abun-
dantly present between days 8 and 12 after infection but 
could still be detected at relatively high frequencies even 28 d 
after virus application (  Fig. 1 I  ). Collectively, these data 
demonstrate that a single i.n. application of the replication-
defi  cient MVA is suffi   cient to induce the long-lasting pres-
ence of highly organized BALT, and that the accumulation 
of CD11c  +   cells around vessels and bronchioles represents 
an early event in its formation. 
    Figure 1.     Induction of BALT after mucosal infection with MVA.  
(A–H) C57/BL6 mice were infected i.n. with 10  7   IU MVA, and at the time 
points indicated (days after infection), lung sections were analyzed by 
fl  uorescence microscopy applying mAb and DAPI as indicated. Represen-
tative sections from three to six mice analyzed for each time point derived 
from two to three different experiments are shown. Bars, 100 μm. (I) The 
number of BALT structures per entire central lung section was determined 
by microscopy (means + SD;   n   = 3–5 animals per time point; pooled data 
are derived from six independent experiments).   b  , bronchioles;   v ,  vessels.   JEM VOL. 206, November 23, 2009  2595
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Although up to 50% of all live cells in the BAL expressed GFP 
at 7 h after infection, only a very small proportion of cells 
were still GFP  +   at 24 h after infection, and no GFP signals 
were detectable at later time points (  Fig. 2 B  ). Because MVA 
cannot produce infectious virions in mammals (  Ramírez et al., 
2000  ), these data indicate that MVA infectivity is rapidly inac-
tivated in vivo. Further analysis revealed that 65% of all BAL 
cells isolated 5–7 h after infection represented alveolar macro-
phages (AMs; CD11c  +  MHCII       ;   Fig. 2 C  ). More than 92% of 
all GFP  +   cells showed this phenotype, with only 4% of 
all GFP  +   cells being conventional DCs (CD11c  +  MHCII  +  ; 
  Fig. 2 D  ). Importantly, the analysis of single-cell suspensions 
prepared by enzymatic digestion of whole-lung tissue yielded 
largely identical results (unpublished data). 
  The rapid decrease of the GFP signal observed shortly 
after infection with MVA-GFP prevented its further use 
in directly tracking the fate of MVA-encoded antigenic 
material. To overcome this limitation, Cy5-labeled MVA 
(MVA-Cy5) was subsequently used for i.n. infection. As 
early as 20 min after MVA-Cy5 inoculation, numerous 
large CD11c  +   cells could be detected carrying MVA-Cy5 
and having the typical location of AMs within the lumen of 
alveoli and airways (  Fig. 2 E  ). In accordance with our data 
derived from i.n. MVA-GFP infection, we could also de-
tect few Cy5  +  CD11b  +  CD11c  +   DCs (  Fig. 2 F  ) in the lungs 
of MVA-Cy5–infected animals. However, the CD11c  +   DC 
network surrounding the conducting airway system did not 
harbor detectable MVA-Cy5 fl  uorescence (unpublished data). 
Analyzing BAL 3 d after infection, a signifi  cant increase 
in the number of DCs (CD11c  +  MHCII  +  ;   Fig. 2 G  ) as well 
as infl  ammatory CD11c       CD11b  hi   cells (  Fig. 2 G  ), such as 
recruited monocytes/macrophages and granulocytes, could 
be observed. At this time point, >20% of the total BAL cells 
still contained MVA-Cy5 (  Fig. 2 H  ). These MVA-Cy5  +   
cells were now exclusively CD11c  +   and/or CD11b  +   cells 
(  Fig. 2 I  , right), with most of them showing a phenotype of DCs 
    Figure 2.     Initial host cell tropism of MVA in the lung.   Mice were i.n. infected with 10  7   IU MVA, and BAL cells were analyzed by fl  ow cytometry. 
(A) GFP expression of DAPI        BAL cells 7 h after infection with MVA-GFP or MVA-WT. (B) GFP expression of BAL 0–72 h after i.n. infection with MVA-GFP 
(mean + SD;   n   = 2–3 mice/time point). (C and D) Expression of CD11c and MHCII on all (C) or GFP  +   (D)  DAPI       BAL cells 7 h after infection with MVA-GFP. 
(E) Immunohistology of lung sections 6 h after i.n. application of Cy5-labeled MVA using antibodies and dyes as indicated. (F) As in E, we obtained sec-
tions from lungs 30 min after MVA-Cy5 application. Bars, 25 μm. (G–I) FACS analysis of BAL cells 3 d after MVA-Cy5 application using antibodies and 
virus as indicated. (G and H) Gate on all DAPI        cells. (I) Gate on all DAPI        MVA-Cy5 +   cells. The FACS plots and immunohistology shown are representative 
of three independent experiments, each with two to three mice analyzed per time point. *, P < 0.05; **, P < 0.01.     2596 BALT function and formation   | Halle et al. 
hours after i.n. application. Most of the infected cells rapidly 
disappear from the lung within a few hours, presumably un-
dergoing apoptosis and/or necrosis, similar to processes found 
after in vitro infection with MVA (  Liu et al., 2008  ). However, 
(CD11c  +  MHCII  +  ) or infl  ammatory cells (CD11b  +  CD11c       ; 
  Fig. 2 I  , left). 
  Collectively, these data indicate that predominantly AMs 
and some DCs are effi     ciently infected with MVA within 
    Figure 3.     i.n. vaccination with recombinant MVA induces a distinct population of antigen-specifi  c cytotoxic T cells in the lung.   (A) Mice i.n. 
received 10  7   IU MVA-Cy5, and 3 d later the phenotype of Cy5  +   cells in the draining LNs was determined by fl  ow cytometry. (B) Expression of CD86 on 
CD11c  + MHCII +   brLN DCs before and 2 d after i.n. instillation of MVA (shaded area, isotype control). (C–G) 1 d after the i.v. transfer of 200 CD45.1  +   CD8 +   OT-I 
T cells into CD45.2  +   recipients, mice were i.n. or i.m. infected with 10  7   IU MVA-OVA. At the indicated time points (days after infection) the absolute number 
of OT-I cells was determined in the brLNs (C), BAL (D), lung (E), and spleen (F). (G) The percentage of OT-I cells expressing CD69 in the lung and spleen. 
(H) Expression of CD3 and CD69 in BALT at 12 d after infection. Bar, 50 μm. Data in A and B are representative of four mice analyzed in two independent experi-
ments. Data shown in C–G are pooled from two independent experiments with two to three mice per time point (means + SD). *, P < 0.05; ***, P < 0.001.    JEM VOL. 206, November 23, 2009  2597
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at the same time, the initial MVA infection initiates a se-
quence of events leading to the recruitment of DCs and in-
fl  ammatory cells that would also allow for the induction of 
adaptive immune responses. 
  Recombinant MVA induces a distinct population 
of antigen-specifi  c cytotoxic T cells in the lung 
after i.n. application 
  After i.n. instillation of MVA-Cy5, we could readily detect 
Cy5  +   cells in the lung-draining bronchial LNs (brLNs). These 
cells were primarily DCs expressing high levels of CD11c 
and MHCII (  Fig. 3 A  ).   The majority of these DCs were 
found to express either CD103 or CD11b (  Fig. 3 A  ). These 
observations, together with the fi  nding that brLN DCs of 
i.n. MVA-infected mice express higher levels of CD86 than 
those of noninfected mice (  Fig. 3 B  ), indicate that the i.n. 
vaccination with MVA can elicit a productive immune re-
sponse in the lung as well as in the lung-draining brLNs. We 
therefore hypothesized that the quality of an adaptive im-
mune response directed against the model antigen OVA in 
the lung might diff  er between mucosal (i.n.) and systemic 
(i.m.) application of MVA encoding chicken OVA (MVA-
OVA). To closely mirror the physiological situation of a small 
starting population of naive T cells being specifi  c for a given 
antigen, we adoptively transferred by i.v. injection 200 OT-I 
T cells (CD45.1  +  ) that recognize the SIINFEKL peptide de-
rived from OVA in an MHC class I–restricted manner into 
CD45.2 recipients 1 d before infection with MVA-OVA via 
the i.n. or i.m. route. 
  After i.n. MVA-OVA application, OT-I T cells could be 
detected at day 4 after infection in the brLNs and spleen 
(  Fig. 3, C and F  ). These cells were also found in the lung and 
BAL (  Fig. 3, D and E  ) starting at day 6. In contrast, after i.m. 
application, only very few OT-I T cells were present in 
brLNs or BAL at any time point investigated (  Fig. 3, C and D  ), 
whereas these cells appeared with similar kinetics and num-
bers in the spleen but less frequently in the lung when com-
pared with i.n.-treated mice (  Fig. 3, E and F  ). Of interest, 
after i.n. but not i.m. application, persistent expression of the 
early activation marker CD69 were observed on a large pro-
portion of OT-I as well as endogenous CD8  +   T cells in the 
lung and BAL (  Fig. 3 G   and not depicted). In contrast, hardly 
any expression of CD69 could be observed on OT-I T cells 
residing in the spleen independent of the route of MVA ap-
plication (  Fig. 3 G  ). Immunohistology of lung sections re-
vealed that CD69  +   T cells were present in BALT (  Fig. 3 H  ). 
  These observations indicate that the application of MVA 
via the respiratory route can induce a local immune response 
that is characterized by the presence of activated antigen-
specifi  c as well as nonspecifi  c CD8  +   T cells in the airways 
(BAL) and BALT that continuously express high levels of CD69. 
The transient up-regulation of CD69 has recently been sug-
gested to inhibit lymphocyte egress from LNs by retaining 
sphingosine 1–phosphate receptor 1, a receptor known to be 
required for lymphocyte exit from LNs into eff  erent lym-
phatics, within intracellular compartments (  Shiow et al., 2006  ). 
It remains to be determined whether CD69 might similarly 
contribute to the retention of lymphocytes within BALT or 
whether continuous CD69 expression represents a general 
feature of T cells present within the lung environment 
(  Kohlmeier et al., 2007  ). 
  Essential role for DCs in BALT maintenance 
  The infi  ltration of CD11c  +   DCs observed within the lungs of 
MVA-infected mice probably represents an early step during 
BALT induction (  Fig. 1 B  ). To address the role of DCs in the 
maintenance of MVA-induced BALT in further detail, we 
i.n. applied diphtheria toxin (DT) to CD11c-DOG mice 
(  Hochweller et al., 2008  ), which express the DT receptor 
(DTR) under the control of the CD11c promoter. The i.n. 
application of DT at days 8 and 10 after MVA infection 
resulted in an efficient depletion of CD11c  +   cells from 
the lung tissue (  Fig. 4 A   and not depicted).   A quantitative 
    Figure 4.     Local depletion of DCs interferes with BALT mainte-
nance.   Mice expressing DTR under the control of the CD11c promoter 
(CD11c-DOG) were infected twice with 10  7   IU MVA. On days 8 and 10, 
mice were treated i.n. with 50 ng DT (+DT) or with PBS (    DT). (A) Lung 
sections from DT-treated or untreated mice stained with DAPI and anti-
CD11c. Bar, 200 μm. (B) Micrographs were quantitatively analyzed for the 
presence of anti-CD11c signals. (C) No change in the percentage of DCs in 
the mesenteric LNs was detected by fl  ow cytometry. Pooled data from 
three experiments, each with one to two mice per group, are shown. 
(D) The number and size of individual BALT structures from DT-treated or 
untreated mice were determined on large composite images of entire lung 
sections (  n   = 6 mice /group in B and D with two to three lung sections per 
mouse in two independent experiments analyzed). Symbols represent the 
mean BALT size per lung, and red bars represent means. ***, P < 0.001.     2598 BALT function and formation   | Halle et al. 
    Figure 5.     Visualization of antigen-specifi  c T cell–DC interactions during T cell priming within BALT.   TAMRA-labeled  CD8 +   OT-I T cells and 
CMAC-labeled polyclonal CD8  +   WT T cells were injected i.v. into BALT-bearing recipients. 24 h later, SIINFEKL-loaded EGFP  +   bone marrow–derived DCs 
(Ag-DCs) were i.t. transferred into the same animals, and lungs were explanted an additional 24 or 48 h later. (A) Cryosections of paraformaldehyde (PFA)-
fi  xated lungs isolated 24 h after i.t. transfer of Ag-DCs into MVA-treated WT mice. (left) EGFP  +   Ag-DCs and TAMRA  +   OT-I T cells localize into BALT. (right) 
Higher magnifi  cation image of a BALT structure harboring Ag-DCs, OT-I T cells, and polyclonal CD8  +   WT T cells. (B) Visualization of BALT within lungs of 
MVA-treated WT (left) or CCR7     /     (right) mice by ex vivo two-photon microscopy. Maximum intensity projections of three-dimensional imaging volumes 
(left: eight Z-slices, 7.5-μm spacing; right: seven Z-slices, 6-μm spacing). Collagen fi  bers surrounding the basal surface of the bronchial epithelium 
(dashed line) are visualized by SHG. Asterisks represent the bronchial lumen, and arrowheads indicate a blood vessel. (C) Analysis of T cell–DC interactions 
within BALT of MVA-treated WT mice by two-photon microscopy (excitation wavelength = 780 nm). 24 h after i.t. transfer of EGFP  +   Ag-DCs,  TAMRA +   OT-I 
T cells exhibit a highly confi  ned migration behavior in the vicinity of Ag-DCs. In contrast, CMAC  +   polyclonal WT control T cells display a much higher mo-
tility (  Video 1  ). (D) The experiment was performed as in C but imaged at 865 nm (  Video 2  ). (E) Motility parameter analysis for OT-I and polyclonal CD8  +   WT 
T cells migrating within BALT 24 h after transfer of Ag-DCs. (left) Dots represent individual cell tracks, and bars indicate median average track speed. 
(middle) Mean displacement plots. (right) Motility coeffi  cient (means + SD). **, P < 0.01. (F) 24 h after i.t. transfer of Ag-DCs into CCR7     /     recipients, 
EGFP  +   DCs were found to enter BALT by directional interstitial migration (arrowhead;   Video 3  ). In contrast, DCs remain largely stationary during Ag pre-
sentation within BALT (dashed yellow box; Video 3). Data in A–F are representative of two to four mice per group in two independent experiments. JEM VOL. 206, November 23, 2009  2599
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generation (SHG) signal resulting from two-photon excita-
tion allowed the additional visualization of collagen fi  bers 
surrounding the basal surface of bronchial epithelium (  Fig. 5 B  ). 
To analyze the cellular dynamics within BALT, lung slices 
were placed in a custom-built incubation chamber and con-
stantly superfused with oxygenated (95% O  2  /5% CO  2  ) me-
dium at 37°C. Imaging BALT ex vivo 24 and 48 h after the 
i.t. transfer of Ag-DCs into MVA-treated WT recipients, we 
found TAMRA-labeled OVA-specifi  c OT-I T cells to inter-
act intensively with EGFP  +   Ag-DCs (  Fig. 5, C and D  ; 
  Videos 1 and 2  ; and not depicted). Interestingly, the observed 
migration and interaction behavior of OT-I T cells in BALT 
was reminiscent of the cellular dynamics reported for CD8  +   
T cells during priming in LNs (  Mempel et al., 2004  ): at 24 h 
after i.t. DC transfer, long-lasting stable contacts between 
OT-I T cells and Ag-DCs were predominant, largely confi  n-
ing the migration of interacting OT-I T cells to DC-rich ar-
eas of BALT (  Fig. 5, C and D;   and Videos 1 and 2). At 48 h 
after i.t. transfer of Ag-DCs, many OT-I T cells were clearly 
enlarged, exhibiting slow swarming movements in the vicin-
ity of EGFP  +   Ag-DCs (unpublished data), probably indicat-
ing the start of their proliferative activity (  Mempel et al., 
2004  ). In contrast, CMAC-labeled polyclonal CD8  +   WT 
T cells did not engage in stable interactions with Ag-DCs at 
either time point (  Fig. 5 C  , Video 1, and not depicted). The 
quantitative analysis of T cell motility parameters revealed 
much lower cellular velocities and displacements, and conse-
quently highly reduced motility coeffi   cient values, for OT-I 
cells when compared with the polyclonal CD8  +   T cell popu-
lation (  Fig. 5 E   and not depicted), further corroborating the 
antigen-specifi  c nature of the observed OT-I T cell–DC in-
teraction behavior in BALT. 
  Although we sometimes observed EGFP  +   Ag-DCs to 
enter BALT by means of a rapid directional interstitial mi-
gration during ex vivo imaging (  Fig. 5 F   and   Video 3  ), it 
seems likely that DCs can reach BALT via aff  erent lymphat-
ics as well. Ag-DCs localized to BALT remained largely 
stationary but exhibited extraordinary probing activity, dis-
playing far-range sweeping dendrite movements during anti-
gen presentation (  Fig. 5, D and F  ; and Videos 2 and 3). We 
next quantitatively analyzed lung cryosections for the maxi-
mum nucleus diameters of TAMRA  +   OT-I T cells as well as 
TAMRA       CD3  +   endogenous T cells present in BALT 48 h 
after i.t. transfer of Ag-DCs (  Fig. 5 G  ). OT-I T cells displayed 
signifi  cantly larger nuclei compared with resting endogenous 
T cells, consistent with the idea that the proliferation of antigen-
specifi  c T cells activated within BALT had already started 
at this time point. Finally, we analyzed the proliferation of 
OT-I T cells by in vivo CFSE dilution at day 4 after the i.t. 
immunohistological analysis showed that the area of CD11c  +   
pixels per lung section was reduced by >90% 2 d after the 
second DT treatment (  Fig. 4 B  ), whereas fl  ow cytometry re-
vealed that DCs in mesenteric LNs were not aff  ected by the 
local application of DT (  Fig. 4 C  ). Of interest, these studies 
also revealed that BALT was strongly reduced in size in the 
DT-treated group (  Fig. 4 D  ), whereas the total number of 
BALT structures per lung was not reduced by DT treatment 
(not depicted). Collectively, these data indicate that DCs play 
an essential role in the maintenance of MVA-induced BALT. 
Because AMs are effi   ciently depleted by this approach as well 
(unpublished data), we currently cannot rule out that these 
cells also contribute to BALT maintenance. However, this 
hypothesis seems unlikely, as AMs are readily depleted within 
1 d after MVA infection (  Fig. 2  ), whereas the DT treatment 
was not started before day 8 after MVA application. 
  BALT serves as a general priming site for T cells 
  The data described so far indicate that the virus-induced for-
mation of BALT participates in generating antivirus immune 
responses. However, although MVA cannot replicate in 
mammals and is rapidly cleared from the lung tissue, MVA-
induced BALT is maintained for several weeks (  Fig. 1 I  ). We 
therefore tested the hypothesis that induced BALT might 
function comparably to a regular lymphoid organ, being able 
to support the de novo priming of naive T cells bearing 
TCR specifi  cities that are not related to the BALT-inducing 
pathogen. To this end, BALT was induced in WT animals 
by i.n. application of MVA-WT. 18 d later, these mice, as 
well as untreated CCR7      /      animals, which constitutively 
develop BALT, received by i.v. injection 2–2.5 × 10  7   
TAMRA-labeled CD8  +   OT-I T cells together with 1.5–2 × 
10  7   CMAC-labeled polyclonal CD8  +   T cells isolated from 
C57BL/6 donors. 24 h later, the animals additionally re-
ceived by intratracheal (i.t.) application LPS-matured EGFP  +   
DCs generated in vitro from the bone marrow of     -actin–
EGFP transgenic mice (  Okabe et al., 1997  ) loaded with 
OVA I peptide (SIINFEKL; Ag-DCs). 
  Immunohistological analysis of lung cryosections by epi-
fl  uorescence microscopy (  Fig. 5 A  ) as well as ex vivo two-
photon imaging of BALT within 1–2-mm thick lung slices 
(  Fig. 5 B  ) revealed that adoptively transferred EGFP  +   Ag-
DCs as well as TAMRA-labeled OT-I T cells and CMAC-
labeled polyclonal T cells were abundantly present in the 
BALT of MVA-treated WT (  Fig. 5, A and B  , left) and un-
treated CCR7      /      (  Fig. 5 B  , right) recipients.   Structural fea-
tures of BALT, such as adjacent bronchi and blood vessels, 
were readily identifi   ed by their characteristic autofl  uores-
cence signals (  Fig. 5, A and B  ), and the second harmonics 
(G) TAMRA  +   OT-I T cells within BALT display enlarged cell bodies and nuclei 48 h after i.t. transfer of Ag-DCs. The maximum diameters of DAPI-stained 
nuclei of TAMRA  +   (OT-I) as well as TAMRA      CD3 +   endogenous T cells within BALT were measured on cryosections. Individual values (dots) and means (red 
bars) of 140 randomly chosen cells from four sections from two mice are shown. ***, P < 0.001. (H) CSFE profi  les of OT-I T cells isolated from the lung, 
brLNs, or mesenteric LNs 4 d after the i.t. transfer of Ag-DCs in mice treated with FTY720 (initial gavage of 1 mg/kg of body weight on day 0, with drink-
ing water supplemented with 2.5 μg/ml FTY720 afterward; representative data of four mice analyzed in two independent experiments). Bars, 50 μm.     
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Invitrogen). 2–2.5 × 10  7   TAMRA-labeled OT-I T cells and 1.5–2 × 10  7   
CMAC-labeled WT T cells were injected i.v. In some experiments, mice 
additionally received 2 × 10  7   unlabeled OT-I T cells as “competitor” cells. 
  Organ preparation.     BAL fl  uid was obtained by fl  ushing the lung two 
times with 1 ml of cold PBS. For lung histology, mice were perfused with 
5 ml of ice-cold PBS. The trachea was cut and a 1:1 mixture of Tissue-Tek 
OCT (Sakura) and PBS was instilled. The lung was removed and snap frozen 
in OCT. 8-μm sections were performed with a cryostat (CM3050; Leica), as 
previously described (  Hintzen et al., 2006  ). 
  Flow cytometry.     Single-cell suspensions were prepared by mechanical dis-
ruption. Lungs were cut into small pieces and digested with 0.5 mg/ml colla-
genase D and 0.025 mg/ml DNase I in RPMI 1640 for 30 min at 37°C. Cells 
were blocked with 5% rat serum, stained, and analyzed with a cytometer 
(LSRII; BD). Data were analyzed using WinList 6.0 (Verity Software House). 
The following antibodies were used: CD103-FITC (M290), CD11c-PE 
(HL3), MHCII-bio (AF6-120.1) detected with streptavidin–Alexa Fluor 750, 
CD11b-PeCy7 (M1/70), CD11b-PE (M1/70), CD86-allophycocyanin 
(APC; GL-1), anti-trinitrolphenol–APC (isotype control), CD69PerCp-
Cy5.5 (H1.2F3), CD69 (H1.2F3), CD127–Alexa Fluor 488 (A7R34), IFN-
    –PE (XMG1.2), CD3-PE (145-2C11), B220-Cy5 (TIB 146), F4/80-PE 
(BM8), and CD11c-bio (HL3) detected with streptavidin–Alexa Fluor 488. 
  Epifl  uorescence microscopy.     Sections were fi  xed in cold acetone, rehy-
drated in Tris-buff  ered saline with 0.05% Tween 20, blocked with 2.5% rat 
and 2.5% mouse serum, and stained at room temperature for 30 min. Pictures 
were taken with a fl  uorescence microscope (Axiovert) using AxioVision 4.6 
software (both from Carl Zeiss, Inc.). 
  BALT area analysis.     Overview pictures of lungs were recorded with the 
mosaic function of the AxioVision software and whole central sections of the 
lungs were analyzed. The total number of BALT structures was measured as 
described previously (  Kocks et al., 2007  ). ImageJ (available at http://rsbweb
.nih.gov/ij/) was used to determine the percentage of CD11c  +   pixel area on 
pictures taken with identical exposure and display settings. 
  i.t. DC transfer.     EGFP  +   bone marrow–derived DCs were generated from 
the bone marrow of     -actin–EGFP transgenic mice (  Okabe et al., 1997  ) by 
in vitro culture (  Ohl et al., 2004  ). After overnight LPS maturation and load-
ing with OVA I peptide (SIINFEKL), 2–6 × 10  6   DCs were resuspended in 
60 μl PBS and transferred i.t. 
  Two-photon microscopy.     Mice were anesthetized with ketamine/xylazine 
and bled to death by cutting the vena cava before harvesting the lungs. 
Horizontal lung slices (thickness = 1–2 mm) were cut with a cryotome 
blade (Leica), immobilized in an imaging chamber (  Fig. S1  ) using tissue ad-
hesive (Abbott), and superfused with oxygenated (95% O  2  /5% CO  2  ) RPMI 
1640 medium (Invitrogen) containing 1% penicillin/streptomycin, 25 mM 
Hepes, and 5 g/liter glucose. Imaging was performed on a TriM Scope 
(LaVision Biotec) equipped with an upright microscope (BX51; Olympus) 
fi  tted with a 20× 0.95 NA water immersion objective and a pulsed infrared 
laser (MaiTai Ti:Sa; Spectra-Physics), tuned to 865 nm for optimal excita-
tion of EGFP and TAMRA and to 780 nm for additional visualization of 
CMAC. To generate time-lapse series, Z-stacks of up to 10 images were 
acquired every 20 s. 
  Data analysis of two-photon imaging was performed as described (  Worbs 
et al., 2007  ), using Imaris 6.2.1 (Bitplane). Only tracks with durations >60 s 
were included in the analysis. Average track speed values were calculated us-
ing Imaris, whereas mean displacement plots and motility coeffi   cients were 
calculated using Visual Basic for Applications (Excel; Microsoft). 
  Statistical analysis.     Statistical analysis was performed with Prism 4 (Graph-
Pad Software, Inc.). All signifi  cant values were determined using the unpaired 
two-tailed   t   test and all error bars represent SDs. Statistical diff  erences for the 
mean values are as follows: *, P < 0.05; **, P < 0.01; and ***, P < 0.001. 
transfer of Ag-DCs (  Fig. 5 H  ). The recipient animals were 
additionally treated with FTY720 to block lymphocyte egress 
from lymphoid organs. The observation that OT-I T cells iso-
lated from the lungs had proliferated as effi   ciently as those 
residing in the brLNs further supports the idea that BALT can 
indeed function as a local priming site for naive T cells. 
  Within this study, we demonstrate that a single i.n. ap-
plication of the replication-defi   cient vaccine virus MVA, 
which effi   ciently infects AMs and DCs, is suffi   cient to in-
duce long-lasting and highly organized BALT in normal 
WT mice. DCs in particular seem to represent key organiz-
ing cells in BALT biology, as they are among the fi  rst cells to 
be recruited into sites of developing BALT (  Fig. 1 B  ) and 
depletion of these cells leads to a pronounced regression in 
BALT size (  Fig. 4  ). Furthermore, antigen-loaded DCs are 
actively migrating into preexisting BALT where they can 
present antigen to naive T cells. 
  Thus, we conclude that induced BALT represents an or-
ganized lymphoid structure for antigen presentation by DCs 
in the lung that is capable of supporting long-lasting T cell–
DC interactions as well as the effi   cient priming of naive T 
cells. Importantly, the antigenic specifi  city of the observed 
priming events (the OVA I peptide SIINFEKL) was com-
pletely diff  erent from the antigenic nature of the stimulus 
that had initially induced the formation of BALT (MVA), 
and occurred long after the complete clearance of the induc-
ing pathogen. Therefore, given its sustained presence, in-
duced BALT can obviously function as a general priming site 
for T cell responses in the lung. 
  MATERIALS AND METHODS 
  Mice.     Mice were bred at a local animal facility or purchased from Charles 
River. CD11c-DOG mice expressing DTR under the control of the CD11c 
promoter were described previously ( Hochweller et al., 2008 ). B6.129P2(C)-
Ccr7  tm1Rfor  /J mice (CCR7      /     ) were backcrossed on the C57BL/6 back-
ground for >15 generations (  Förster et al., 1999  ). In some experiments, DCs 
were diff  erentiated from the bone marrow of     -actin–GFP mice (  Okabe 
et al., 1997  ) using previously described protocols (  Ohl et al., 2004  ). Animal 
protocols were approved by the institutional review board and the Nieder-
sächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit. 
  MVA.     Recombinant MVA constructs have been described previously (  Staib 
et al., 2000  ;   Albrecht et al., 2008  ). Virus stocks were generated by standard 
methods (  Sutter and Moss, 1992  ). In brief, viruses were propagated on pri-
mary chicken embryo fi  broblasts (CEFs), purifi  ed by sucrose gradient cen-
trifugation, and titrated on CEFs to determine infectious units. Labeling of 
MVA with the fl  uorescent dye Cy5 was performed as described by the man-
ufacturer (GE Healthcare). 
  i.n. inoculation.     Mice were deeply anaesthetized with ketamine/xylazine, 
and 10  7   IU MVA diluted in 50 μl PBS was applied to the nostrils. For the 
depletion of CD11c  +   cells from the lung, CD11c-DOG mice were i.n. 
treated with 50 ng DT (Sigma-Aldrich) in 50 μl PBS. 
  T cell transfer.     Blood was taken from CD45.1  +   OT-I donors, and 200 
CD8  +   TCR V    5  +   OT-I cells were injected i.v. into recipients (  Fig. 3  ). For 
two-photon imaging, CD8  +   T cells from OT-I or WT donors were sorted 
to a purity of 90–95% using a MACS CD8  +   T cell isolation kit applying an 
AutoMACS (Miltenyi Biotec). OT-I T cells were labeled with 15 μM 
TAMRA, whereas WT T cells were labeled with 15 μM CMAC (both from JEM VOL. 206, November 23, 2009  2601
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  Online supplemental material.     Fig. S1 depicts a custom-built incubation 
chamber. Video 1 shows T cell migration and interaction behavior within 
MVA-induced BALT 24 h after i.t. transfer of Ag-DCs. Video 2 shows DC 
probing and T cell–DC interaction dynamics within MVA-induced BALT 
24 h after i.t. transfer of Ag-DCs in the presence of unlabeled competitor 
OT-I cells. Video 3 shows directional DC migration toward BALT and ac-
tive DC dendrite movement during T cell priming 24 h after i.t. transfer of 
Ag-DCs. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20091472/DC1. 
  This work was supported by Deutsche Forschungsgemeinschaft (DFG) grant 
SFB587-B3 to R. Förster and in part by the DFG Excellence Cluster in the area of 
Regenerative Biology and Reconstructive Therapies. 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   8 July 2009 
Accepted:   14 October 2009 
  REFERENCES 
      Albrecht  ,   M.  ,   Y.     Suezer  ,   C.     Staib  ,   G.     Sutter  ,   S.     Vieths  , and   G.     Reese  .   2008  . 
  Vaccination with a Modifi   ed Vaccinia Virus Ankara-based vaccine 
protects mice from allergic sensitization.       J. Gene Med.       10  :  1324  –  1333  . 
  doi:10.1002/jgm.1256     
      Bienenstock  ,   J.  , and   D.     Befus  .   1984  .   Gut- and bronchus-associated lym-
phoid tissue.       Am. J. Anat.       170  :  437  –  445  .   doi:10.1002/aja.1001700316     
      Corbett  ,   M.  ,   W.M.     Bogers  ,   J.L.     Heeney  ,   S.     Gerber  ,   C.     Genin  ,   A.   
  Didierlaurent  ,   H.     Oostermeijer  ,   R.     Dubbes  ,   G.     Braskamp  ,   S.     Lerondel  , 
  et al  .   2008  .   Aerosol immunization with NYVAC and MVA vectored 
vaccines is safe, simple, and immunogenic.       Proc. Natl. Acad. Sci. USA      .   
  105  :  2046  –  2051  .   doi:10.1073/pnas.0705191105     
      Förster  ,   R.  ,   A.     Schubel  ,   D.     Breitfeld  ,   E.     Kremmer  ,   I.     Renner-Müller  ,   E.   
  Wolf  , and   M.     Lipp  .   1999  .   CCR7 coordinates the primary immune re-
sponse by establishing functional microenvironments in secondary lym-
phoid organs.       Cell      .     99  :  23  –  33  .   doi:10.1016/S0092-8674(00)80059-8     
      Gherardi  ,   M.M.  , and   M.     Esteban  .   2005  .   Recombinant poxviruses as mucosal 
vaccine vectors.       J. Gen. Virol.       86  :  2925  –  2936  .   doi:10.1099/vir.0.81181-0     
      Hintzen  ,   G.  ,   L.     Ohl  ,   M.L.     del Rio  ,   J.I.     Rodriguez-Barbosa  ,   O.     Pabst  ,   J.R.   
  Kocks  ,   J.     Krege  ,   S.     Hardtke  , and   R.     Förster  .   2006  .   Induction of toler-
ance to innocuous inhaled antigen relies on a CCR7-dependent den-
dritic cell-mediated antigen transport to the bronchial lymph node.   
    J. Immunol.       177  :  7346  –  7354  .   
      Hochweller  ,   K.  ,   J.     Striegler  ,   G.J.     Hämmerling  , and   N.     Garbi  .   2008  .   A novel 
CD11c.DTR transgenic mouse for depletion of dendritic cells reveals 
their requirement for homeostatic proliferation of natural killer cells.   
    Eur. J. Immunol.       38  :  2776  –  2783  .   doi:10.1002/eji.200838659     
      Kastenmuller  ,   W.  ,   G.     Gasteiger  ,   L.     Stross  ,   D.H.     Busch  , and   I.     Drexler  .   2009  . 
  Cutting edge: mucosal application of a lyophilized viral vector vaccine 
confers systemic and protective immunity toward intracellular patho-
gens.       J. Immunol.       182  :  2573  –  2577  .   doi:10.4049/jimmunol.0803871     
      Kocks  ,   J.R.  ,   A.C.     Davalos-Misslitz  ,   G.     Hintzen  ,   L.     Ohl  , and   R.     Förster  . 
  2007  .   Regulatory T cells interfere with the development of bronchus-
associated lymphoid tissue.       J. Exp. Med.       204  :  723  –  734  .   doi:10.1084/jem
.20061424     
      Kocks  ,   J.R.  ,   H.     Adler  ,   H.     Danzer  ,   K.     Hoff  mann  ,   D.     Jonigk  ,   U.     Lehmann  , 
and   R.     Förster  .   2009  .   Chemokine receptor CCR7 contributes to a rapid 
and effi   cient clearance of lytic murine gamma-herpes virus 68 from the 
lung, whereas bronchus-associated lymphoid tissue harbors virus during 
latency.       J. Immunol.       182  :  6861  –  6869  .   doi:10.4049/jimmunol.0801826     
      Kohlmeier  ,   J.E.  ,   S.C.     Miller  , and   D.L.     Woodland  .   2007  .   Cutting edge: 
antigen is not required for the activation and maintenance of virus-
specifi   c memory CD8+ T cells in the lung airways.       J. Immunol.     
  178  :  4721  –  4725  .   
      Lehmann  ,   M.H.  ,   W.     Kastenmuller  ,   J.D.     Kandemir  ,   F.     Brandt  ,   Y.     Suezer  , 
and   G.     Sutter  .   2009  .   Modifi  ed vaccinia virus Ankara triggers chemo-
taxis of monocytes and early respiratory immigration of leukocytes by 
induction of CCL2 expression.       J. Virol.       83  :  2540  –  2552  .   doi:10.1128/JVI
.01884-08     
      Liu  ,   L.  ,   R.     Chavan  , and   M.B.     Feinberg  .   2008  .   Dendritic cells are preferen-
tially targeted among hematolymphocytes by Modifi  ed Vaccinia Virus 
Ankara and play a key role in the induction of virus-specifi  c T cell re-
sponses in vivo.       BMC Immunol.       9  :  15  .   doi:10.1186/1471-2172-9-15     
      Lührmann  ,   A.  ,   T.     Tschernig  , and   R.     Pabst  .   2002/2003  .   Stimulation of 
bronchus-associated lymphoid tissue in rats by repeated inhalation of 
aerosolized lipopeptide MALP-2.     Pathobiology      .    70  :  266  –  269  .  doi:10.1159/
000070740     
      Mempel  ,   T.R.  ,   S.E.     Henrickson  , and   U.H.     von Andrian  .   2004  .   T-cell prim-
ing by dendritic cells in lymph nodes occurs in three distinct phases.   
    Nature      .     427  :  154  –  159  .   doi:10.1038/nature02238     
      Meyer  ,  H.  ,  G.    Sutter  , and  A.    Mayr  .  1991  .  Mapping of deletions in the genome 
of the highly attenuated vaccinia virus MVA and their infl  uence on viru-
lence.       J. Gen. Virol.       72  :  1031  –  1038  .   doi:10.1099/0022-1317-72-5-1031     
      Moyron-Quiroz  ,   J.E.  ,   J.     Rangel-Moreno  ,   K.     Kusser  ,   L.     Hartson  ,   F.     Sprague  , 
  S.     Goodrich  ,   D.L.     Woodland  ,   F.E.     Lund  , and   T.D.     Randall  .   2004  .   Role 
of inducible bronchus associated lymphoid tissue (iBALT) in respiratory 
immunity.       Nat. Med.       10  :  927  –  934  .   doi:10.1038/nm1091     
      Ohl  ,   L.  ,   M.     Mohaupt  ,   N.     Czeloth  ,   G.     Hintzen  ,   Z.     Kiafard  ,   J.     Zwirner  ,   T.   
  Blankenstein  ,   G.     Henning  , and   R.     Förster  .   2004  .   CCR7 governs skin 
dendritic cell migration under infl  ammatory and steady-state conditions.   
    Immunity      .     21  :  279  –  288  .   doi:10.1016/j.immuni.2004.06.014     
      Okabe  ,   M.  ,   M.     Ikawa  ,   K.     Kominami  ,   T.     Nakanishi  , and   Y.     Nishimune  . 
  1997  .   “Green mice” as a source of ubiquitous green cells.       FEBS Lett.     
  407  :  313  –  319  .   doi:10.1016/S0014-5793(97)00313-X     
      Ramírez  ,   J.C.  ,   M.M.     Gherardi  , and   M.     Esteban  .   2000  .   Biology of attenu-
ated modifi  ed vaccinia virus Ankara recombinant vector in mice: virus 
fate and activation of B- and T-cell immune responses in comparison 
with the Western Reserve strain and advantages as a vaccine.       J. Virol.     
  74  :  923  –  933  .   doi:10.1128/JVI.74.2.923-933.2000     
      Shiow  ,   L.R.  ,   D.B.     Rosen  ,   N.     Brdicková  ,   Y.     Xu  ,   J.     An  ,   L.L.     Lanier  ,   J.G.   
  Cyster  , and   M.     Matloubian  .   2006  .   CD69 acts downstream of interferon-
alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid or-
gans.       Nature      .     440  :  540  –  544  .   doi:10.1038/nature04606     
      Sminia  ,   T.  ,   G.J.     van der Brugge-Gamelkoorn  , and   S.H.     Jeurissen  .   1989  . 
  Structure and function of bronchus-associated lymphoid tissue (BALT).   
    Crit. Rev. Immunol.       9  :  119  –  150  .   
      Staib  ,   C.  ,   I.     Drexler  ,   M.     Ohlmann  ,   S.     Wintersperger  ,   V.     Erfl  e  , and   G.     Sutter  . 
  2000  .   Transient host range selection for genetic engineering of modifi  ed 
vaccinia virus Ankara.       Biotechniques      .     28  :  1137  –  1148  .   
      Sutter  ,   G.  , and   B.     Moss  .   1992  .   Nonreplicating vaccinia vector effi   ciently ex-
presses recombinant genes.       Proc. Natl. Acad. Sci. USA      .     89  :  10847  –  10851  . 
  doi:10.1073/pnas.89.22.10847     
      Tschernig  ,   T.  , and   R.     Pabst  .   2000  .   Bronchus-associated lymphoid tissue 
(BALT) is not present in the normal adult lung but in diff  erent diseases.   
    Pathobiology      .     68  :  1  –  8  .   doi:10.1159/000028109     
      Worbs  ,   T.  ,   T.R.     Mempel  ,   J.     Bölter  ,   U.H.     von Andrian  , and   R.     Förster  . 
  2007  .   CCR7 ligands stimulate the intranodal motility of T lymphocytes 
in vivo.       J. Exp. Med.       204  :  489  –  495  .   doi:10.1084/jem.20061706     
      Xu  ,   B.  ,   N.     Wagner  ,   L.N.     Pham  ,   V.     Magno  ,   Z.     Shan  ,   E.C.     Butcher  , and 
  S.A.     Michie  .   2003  .   Lymphocyte homing to bronchus-associated lym-
phoid tissue (BALT) is mediated by     L  -  selectin/PNAd,     4    1 integrin/
VCAM-1, and LFA-1 adhesion pathways.       J. Exp. Med.       197  :  1255  –  1267  . 
  doi:10.1084/jem.20010685                           